DORMAZOLAM DIN 02517582
Status: Marketed
Holder: DECHRA REGULATORY BV
Health Canada record
| Active ingredient(s) | MIDAZOLAM 5 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 21-Dec-2021 |
|---|
| Current status date | 21-Dec-2021 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MIDAZOLAM
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02240285 | MIDAZOLAM INJECTION | SANDOZ CANADA INCORPORATED | Solution | MIDAZOLAM 1 MG | Marketed |
| 02240286 | MIDAZOLAM INJECTION | SANDOZ CANADA INCORPORATED | Solution | MIDAZOLAM 5 MG | Marketed |
| 02553104 | MIDAZOLAM INJECTION USP | HIKMA CANADA LIMITED | Solution | MIDAZOLAM 1 MG | Marketed |
| 02382342 | MIDAZOLAM INJECTION USP | PFIZER CANADA ULC | Solution | MIDAZOLAM 1 MG | Marketed |
| 02382350 | MIDAZOLAM INJECTION USP | PFIZER CANADA ULC | Solution | MIDAZOLAM 5 MG | Marketed |
| 02382377 | MIDAZOLAM INJECTION USP | PFIZER CANADA ULC | Solution | MIDAZOLAM 1 MG | Marketed |
| 02382385 | MIDAZOLAM INJECTION USP | PFIZER CANADA ULC | Solution | MIDAZOLAM 5 MG | Marketed |
| 02498022 | MIDAZOLAM INJECTION USP | STERINOVA INC. | Solution | MIDAZOLAM 1 MG | Marketed |
| 02529300 | MIDAZOLAM INJECTION, USP | BAXTER CORPORATION | Solution | MIDAZOLAM 1 MG | Approved |
| 02242904 | MIDAZOLAM INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | MIDAZOLAM 1 MG | Marketed |
| 02529319 | MIDAZOLAM INJECTION, USP | BAXTER CORPORATION | Solution | MIDAZOLAM 5 MG | Approved |
| 02242905 | MIDAZOLAM INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | MIDAZOLAM 5 MG | Marketed |
| 02423766 | MIDAZOLAM INJECTION | PFIZER CANADA ULC | Solution | MIDAZOLAM 5 MG | Cancelled Post Market |
| 02423758 | MIDAZOLAM INJECTION | PFIZER CANADA ULC | Solution | MIDAZOLAM 1 MG | Cancelled Post Market |
| 02382873 | MIDAZOLAM INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | MIDAZOLAM 1 MG | Dormant |
| 02382903 | MIDAZOLAM INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | MIDAZOLAM 5 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 26165 | 2021-06-29 | New Drug Submission (NDS) | |
International API supply for MIDAZOLAM
7 valid EDQM Certificates of Suitability from 7 holders. 9 active FDA Drug Master Files.
Request a quote for DORMAZOLAM
How to read a Canadian DIN record